Report of a fulminant anti-pan-neurofascin-associated neuropathy responsive to rituximab and bortezomib.
Fels M, Fisse AL, Schwake C, Motte J, Athanasopoulos D, Grüter T, Spenner M, Breuer T, Starz K, Heinrich D, Grond M, Keyvani K, Appeltshauser L, Doppler K, Sommer C, Ayzenberg I, Schneider-Gold C, Gold R, Pitarokoili K, Labedi A.
Fels M, et al.
J Peripher Nerv Syst. 2021 Dec;26(4):475-480. doi: 10.1111/jns.12465. Epub 2021 Sep 7.
J Peripher Nerv Syst. 2021.
PMID: 34486194
Therapeutic strategies are needed as symptoms may be life-threatening and may not respond to standard first-line CIDP treatment. We report a case of a 52-year-old male with a rare anti-pan-neurofascin (NF) (-155, -186/-140)-associated neuropathy. The initial presentation w …
Therapeutic strategies are needed as symptoms may be life-threatening and may not respond to standard first-line CIDP treatment. We report a …